The prevalence of anemia in chronic heart failure

This publication has 17 references indexed in Scilit:

• The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
  Journal of the American College of Cardiology, 2001
• The pathological consequences of anaemia
  Clinical and Laboratory Haematology, 2001
• IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000
  American Journal of Kidney Diseases, 2001
• Pathophysiology of anaemia: focus on the heart and blood vessels
  Nephrology Dialysis Transplantation, 2000
• Management of early renal anaemia: diagnostic work‐up, iron therapy, epoetin therapy
  Nephrology Dialysis Transplantation, 2000
• The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
  Published by Elsevier ,2000
• The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry
  Nephrology Dialysis Transplantation, 1998
• Renal Anaemia Treatment with Recombinant Human Erythropoietin Increases Cardiac Output in Patients with Ischaemic Heart Disease
  Scandinavian Journal of Urology and Nephrology, 1996
• Therapy with Recombinant Human Erythropoietin Reduces Cardiac Size and Improves Heart Function in Chronic Hemodialysis Patients
  American Journal of Nephrology, 1991
• Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin
  The Lancet, 1990